Cetera Advisor Networks’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $5.1M | Buy |
53,729
+11,023
| +26% | +$1.02M | 0.03% | 623 |
|
|
2023
Q4 | $3.81M | Buy |
42,706
+3,956
| +10% | +$294K | 0.02% | 692 |
|
|
2023
Q3 | $2.83M | Buy |
38,750
+2,627
| +7% | +$210K | 0.02% | 757 |
|
|
2023
Q2 | $3.01M | Sell |
36,123
-1,065
| -3% | -$89.1K | 0.02% | 709 |
|
|
2023
Q1 | $2.83M | Sell |
37,188
-7,085
| -16% | -$588K | 0.02% | 715 |
|
|
2022
Q4 | $3.67M | Buy |
44,273
+5,437
| +14% | +$440K | 0.03% | 568 |
|
|
2022
Q3 | $3.08M | Buy |
38,836
+1,355
| +4% | +$114K | 0.04% | 455 |
|
|
2022
Q2 | $2.78M | Buy |
37,481
+1,821
| +5% | +$137K | 0.04% | 481 |
|
|
2022
Q1 | $3.21M | Buy |
35,660
+3,935
| +12% | +$363K | 0.04% | 450 |
|
|
2021
Q4 | $3.55M | Buy |
31,725
+3,308
| +12% | +$399K | 0.04% | 405 |
|
|
2021
Q3 | $3.57M | Buy |
28,417
+5,315
| +23% | +$684K | 0.05% | 358 |
|
|
2021
Q2 | $3.13M | Buy |
23,102
+3,984
| +21% | +$524K | 0.04% | 388 |
|
|
2021
Q1 | $2.59M | Buy |
19,118
+276
| +1% | +$41.3K | 0.06% | 308 |
|
|
2020
Q4 | $2.65M | Buy |
18,842
+2,795
| +17% | +$358K | 0.06% | 284 |
|
|
2020
Q3 | $1.79M | Sell |
16,047
-1,968
| -11% | -$221K | 0.05% | 325 |
|
|
2020
Q2 | $2.02M | Sell |
18,015
-95
| -0.5% | -$9.36K | 0.05% | 299 |
|
|
2020
Q1 | $1.4M | Sell |
18,110
-3,702
| -17% | -$328K | 0.05% | 336 |
|
|
2019
Q4 | $2.09M | Sell |
21,812
-102
| -0.5% | -$8.82K | 0.06% | 288 |
|
|
2019
Q3 | $1.68M | Sell |
21,914
-3,573
| -14% | -$297K | 0.05% | 309 |
|
|
2019
Q2 | $2.24M | Buy |
25,487
+8,862
| +53% | +$756K | 0.07% | 252 |
|
|
2019
Q1 | $1.5M | Sell |
16,625
-4,787
| -22% | -$407K | 0.05% | 306 |
|
|
2018
Q4 | $1.54M | Sell |
21,412
-14,208
| -40% | -$1.14M | 0.06% | 276 |
|
|
2018
Q3 | $3.43M | Buy |
35,620
+11,240
| +46% | +$1.09M | 0.12% | 155 |
|
|
2018
Q2 | $2.34M | Buy |
24,380
+6,150
| +34% | +$565K | 0.12% | 149 |
|
|
2018
Q1 | $1.6M | Buy |
18,230
+3,930
| +27% | +$359K | 0.07% | 227 |
|
|
2017
Q4 | $1.21M | Buy |
14,300
+1,018
| +8% | +$85.3K | 0.05% | 308 |
|
|
2017
Q3 | $1.15M | Buy |
13,282
+1,090
| +9% | +$87.4K | 0.05% | 302 |
|
|
2017
Q2 | $941K | Buy |
12,192
+999
| +9% | +$70.9K | 0.04% | 339 |
|
|
2017
Q1 | $778K | Sell |
11,193
-7,486
| -40% | -$503K | 0.04% | 375 |
|
|
2016
Q4 | $1.11M | Buy |
18,679
+12,816
| +219% | +$791K | 0.06% | 278 |
|
|
2016
Q3 | $389K | Buy |
5,863
+1,564
| +36% | +$96.8K | 0.01% | 667 |
|
|
2016
Q2 | $228K | Sell |
4,299
-401
| -9% | -$22K | 0.01% | 718 |
|
|
2016
Q1 | $241K | Sell |
4,700
-1,134
| -19% | -$58.9K | 0.02% | 687 |
|
|
2015
Q4 | $410K | Sell |
5,834
-27
| -0.5% | -$1.84K | 0.03% | 495 |
|
|
2015
Q3 | $367K | Buy |
5,861
+1,568
| +37% | +$124K | 0.03% | 514 |
|
|
2015
Q2 | $324K | Hold |
4,293
| – | – | 0.02% | 595 |
|
|
2015
Q1 | $324K | Buy |
4,293
+900
| +27% | +$62.9K | 0.02% | 599 |
|
|
2014
Q4 | $210K | Buy |
+3,393
| New | +$193K | 0.01% | 736 |
|
Other funds holding XBI
ACA
Cetera Advisor Networks's XBI Position: Q1 2024 in Review
Cetera Advisor Networks increased its State Street SPDR S&P Biotech ETF (XBI) stake by 26% in Q1 2024, buying an estimated $1.02M and bringing the position to 53,729 shares worth $5.1M. The position accounts for 0.03% of the portfolio, ranked #623.
Cetera Advisor Networks first reported a position in XBI in Q4 2014 and has held it in 38 quarters since. 780 funds tracked by Wall St. Rank hold XBI as of Q1 2024.
- Cetera Advisor Networks held 53,729 shares of State Street SPDR S&P Biotech ETF worth $5.1M as of Q1 2024.
- Cetera Advisor Networks bought 11,023 State Street SPDR S&P Biotech ETF shares in Q1 2024, an estimated $1.02M.
- State Street SPDR S&P Biotech ETF made up 0.03% of Cetera Advisor Networks's portfolio in Q1 2024, its #623 holding.
- Cetera Advisor Networks first reported a position in State Street SPDR S&P Biotech ETF in Q4 2014 and has held it in 38 quarters since.
- 780 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2024.
Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.